Last modified: 2014-04-03
Abstract
Background: Anti-NMDAR encephalitis is an autoimmune disorder characterized by memory deficit, decreased level of consciousness, autonomic dysfunction and movement disorders. It occurs commonly in children and young adolescent .We report 2 cases with anti-NMDAR encephalitis presented to the pediatric emergency department at King Khalid University Hospital(KKUH).To our knowledge this is the first report from Saudi Arabia.
Case (1):A 4-year-old girl presented with sudden onset of seizure and behavioral changes followed by deterioration in her mental status and abnormal movements . Her Clinical Examination revealed normal vital signs, poor social interaction, Oro-facial dyskinesia, chorioathetosis and dystonia . Brain MRI was unremarkable .Electroencephalography( EEG) showed delta slowing . Cerebrospinal fluid (CSF) analysis was negative for infection. Anti-NMDAR antibodies was positive in both serum and CSF.Screening for underlying malignancy was negative.Marked improvement was noted after treatment with corticosteroid ,intravenous immunoglobulin ( IVIg) and rituximab.
Case (2): A 6- year-old girl presented with five days history of behavioral changes and insomnia associated with fluctuation in the level of consciousness and involuntary movements .Her clinical examination revealed minimally interactive,autonomic manifestations,oro-facial dyskinesia and chorioathetosis. MRI brain was unremarkable,EEG showed diffuse delta slowing .CSF analysis was negative for infection. Anti-NMDAR antibodies was positive in both serum and CSF.Screening for underlying malignancy was negative.She was given IVIg ,corticosteroid and rituximab and showed marked improvement .
Conclusion: Anti-NMDAR encephalitis is a new,under-recognized disorder.Early recognition and high index of suspicion is very important in initiation of different modality of treatments which lead to favorable outcome.
Keywords
References
1.Dalmau, J., et al., Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol, 2007. 61(1): p. 25-36.
2.Dalmau, J., et al., Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol, 2011. 10(1): p. 63-74.
3.Florance, N.R., et al., Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol, 2009. 66(1): p. 11-8.
4.Dale, R.C., S. Pillai, and F. Brilot, Cerebrospinal fluid CD19(+) B-cell expansion in N-methyl-D-aspartate receptor encephalitis. Dev Med Child Neurol, 2013. 55(2): p. 191-3.